Titers and types of antineutrophil cytoplasmic antibodies (ANCAs) and titers of antinuclear antibodies (ANAs) and smooth muscle antibodies (ASMAs) contained in intravenous immunoglobulin preparations as demonstrated by IIF
. | ANCA IgG . | ANCA IgA . | ANCA IgM . | ANA IgG . | ASMA IgG . |
---|---|---|---|---|---|
A1 | 1:1024* | 1:512* | 1:16* | 1:120† | 1:240‡ |
A2 | 1:1024* | 1:512* | 1:64* | 1:60† | 1:240‡ |
A3 | 1:512* | 1:512* | 1:32* | 1:60† | 1:240‡ |
A4 | 1:512* | 1:256* | 1:32* | 1:30† | 1:120‡ |
A5 | 1:2048* | NT | NT | NT | NT |
B1 | 1:32* | – | – | 1:120† | – |
B2 | 1:128* | 1:8* | – | 1:60† | – |
C1 | 1:64* | – | – | 1:30† | – |
C2 | 1:64* | NT | NT | NT | NT |
D1 | 1:64§ | 1:128* | 1:256§ | 1:120† | – |
D2 | 1:64* | NT | NT | NT | NT |
D3 | 1:256* | NT | NT | NT | NT |
E1 | 1:256* | 1:16* | – | 1:240† | – |
. | ANCA IgG . | ANCA IgA . | ANCA IgM . | ANA IgG . | ASMA IgG . |
---|---|---|---|---|---|
A1 | 1:1024* | 1:512* | 1:16* | 1:120† | 1:240‡ |
A2 | 1:1024* | 1:512* | 1:64* | 1:60† | 1:240‡ |
A3 | 1:512* | 1:512* | 1:32* | 1:60† | 1:240‡ |
A4 | 1:512* | 1:256* | 1:32* | 1:30† | 1:120‡ |
A5 | 1:2048* | NT | NT | NT | NT |
B1 | 1:32* | – | – | 1:120† | – |
B2 | 1:128* | 1:8* | – | 1:60† | – |
C1 | 1:64* | – | – | 1:30† | – |
C2 | 1:64* | NT | NT | NT | NT |
D1 | 1:64§ | 1:128* | 1:256§ | 1:120† | – |
D2 | 1:64* | NT | NT | NT | NT |
D3 | 1:256* | NT | NT | NT | NT |
E1 | 1:256* | 1:16* | – | 1:240† | – |